Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gordon Joyce

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Cell|April 27, 2016
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GGuillaume B E Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.
Vaccines|October 28, 2025
Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient TransfectionAgnes Hajduczki, William C Chang, Rafael De La Barrera, et al.
Nature Medicine|November 8, 2016
Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccinationJiwon Lee, Daniel R Boutz, Veronika Chromikova, et al.
Science Immunology|April 21, 2019
Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccineKenta Matsuda, Jinghe Huang, Tongqing Zhou, et al.
Cell Reports. Medicine|April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaquesJingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Science Translational Medicine|March 17, 2017
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptideS Munir Alam, Baptiste Aussedat, Yusuf Vohra, et al.
JCI Insight|January 31, 2020
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functionsDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Nature Structural & Molecular Biology|December 23, 2015
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine designJason Gorman, Cinque Soto, Max M Yang, et al.
Cell|September 10, 2016
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor RepertoiresMing Tian, Cheng Cheng, Xuejun Chen, et al.
Science Advances|November 23, 2022
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFNJingyou Yu, Paul V Thomas, Katherine McMahan, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Cell|April 27, 2016
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GGuillaume B E Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.
Vaccines|October 28, 2025
Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient TransfectionAgnes Hajduczki, William C Chang, Rafael De La Barrera, et al.
Nature Medicine|November 8, 2016
Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccinationJiwon Lee, Daniel R Boutz, Veronika Chromikova, et al.
Science Immunology|April 21, 2019
Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccineKenta Matsuda, Jinghe Huang, Tongqing Zhou, et al.
Cell Reports. Medicine|April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaquesJingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Science Translational Medicine|March 17, 2017
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptideS Munir Alam, Baptiste Aussedat, Yusuf Vohra, et al.
JCI Insight|January 31, 2020
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functionsDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Nature Structural & Molecular Biology|December 23, 2015
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine designJason Gorman, Cinque Soto, Max M Yang, et al.
Cell|September 10, 2016
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor RepertoiresMing Tian, Cheng Cheng, Xuejun Chen, et al.
Science Advances|November 23, 2022
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFNJingyou Yu, Paul V Thomas, Katherine McMahan, et al.
Pageof 11